Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 512562, 8 pages
http://dx.doi.org/10.1155/2014/512562
Research Article

Effects of Chinese Formula Jueyin Granules on Psoriasis in an Animal Model

1Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai 200437, China
2Department of Pharmacy, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

Received 12 May 2014; Revised 26 June 2014; Accepted 5 July 2014; Published 4 August 2014

Academic Editor: Karl Wah-Keung Tsim

Copyright © 2014 Tian Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Naldi, “Epidemiology of psoriasis,” Current Drug Targets: Inflammation and Allergy, vol. 3, no. 2, pp. 121–128, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Wang and Y. Liu, “Traditional Chinese medicine is effective and safe in the treatment of psoriasis,” International Journal of Dermatology, vol. 43, no. 7, p. 552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. W. Corson and C. M. Crews, “Molecular understanding and modern application of traditional medicines: triumphs and trials,” Cell, vol. 130, no. 5, pp. 769–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F.-L. Li, R. X. Xu, Q.-C. Zeng et al., “Tanshinone IIA inhibits growth of keratinocytes through cell cycle arrest and apoptosis: underlying treatment mechanism of psoriasis,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 927658, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ş. Aktürk, H. K. Özdoǧan, D. Bayramgürler, M. B. Çekmen, N. Bilen, and R. Kiran, “Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients,” Journal of the European Academy of Dermatology and Venereology, vol. 26, no. 7, pp. 833–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. D. P. Kadam, A. N. Suryakar, R. D. Ankush, C. Y. Kadam, and K. H. Deshpande, “Role of oxidative stress in various stages of psoriasis,” Indian Journal of Clinical Biochemistry, vol. 25, no. 4, pp. 388–392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Chen, R. Xu, X. Li et al., “Differences in the quantity of Th1/Th17 cells among patients with psoriasis of different syndromes,” Chinese Journal of Dermatology, vol. 46, no. 3, pp. 172–175, 2013. View at Google Scholar
  8. L. Van Der Fits, S. Mourits, J. S. A. Voerman et al., “Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis,” Journal of Immunology, vol. 182, no. 9, pp. 5836–5845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. H. Bonder and E. J. van Scott, “Use of mouse vaginal and rectal epithelium to screen antimitotic effects of systemically administered drugs,” Cancer Research, vol. 31, no. 6, pp. 851–853, 1971. View at Google Scholar · View at Scopus
  10. N. J. Lowe, R. B. Stoughton, J. L. McCullough, and G. D. Weinstein, “Topical drug effects on normal and proliferating epidermal cell models. Comparison with response in psoriatics,” Archives of Dermatology, vol. 117, no. 7, pp. 394–398, 1981. View at Publisher · View at Google Scholar · View at Scopus
  11. A. du Vivier and R. B. Stoughton, “An animal model for screening topical and systemic drugs for potential use in the treatment of psoriasis,” Journal of Investigative Dermatology, vol. 65, no. 2, pp. 235–237, 1975. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. K. Lin, C. J. Chang, Y. C. Chang, W. R. Wong, S. C. Chang, and J. S. Pang, “Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis,” Archives of Dermatology, vol. 144, no. 11, pp. 1457–1464, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Wang and Y. Liu, “Traditional Chinese medicine is effective and safe in the treatment of psoriasis,” International Journal of Dermatology, vol. 43, article 552, no. 7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Li, B. Li, R. Xu, X. Song, Y. Yu, and Z. Xu, “Qinzhu Liangxue Decoction in treatment of blood-heat type psoriasis vulgaris: a randomized controlled trial,” Journal of Chinese Integrative Medicine, vol. 6, no. 6, pp. 586–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Flutter and F. O. Nestle, “TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis,” European Journal of Immunology, vol. 43, no. 12, pp. 3138–3146, 2013. View at Google Scholar
  16. P. L. Stern, S. H. van der Burg, I. N. Hampson et al., “Therapy of human papillomavirus-related disease,” Vaccine, vol. 30, supplement 5, pp. F71–F82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Yildirim, H. S. Inaloz, V. Baysal, and N. Delibas, “The role of oxidants and antioxidants in psoriasis,” Journal of the European Academy of Dermatology and Venereology, vol. 17, no. 1, pp. 34–36, 2003. View at Publisher · View at Google Scholar · View at Scopus